Approximate Analytical Solution of a Cancer Immunotherapy Model by the Application of Differential Transform and Adomian Decomposition Methods

Clicks: 86
ID: 281557
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #309 of 803 articles by views in arXiv

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 803 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Immunotherapy plays a major role in tumour treatment, in comparison with other methods of dealing with cancer. The Kirschner-Panetta (KP) model of cancer immunotherapy describes the interaction between tumour cells, effector cells and interleukin-2 which are clinically utilized as medical treatment. The model selects a rich concept of immune-tumour dynamics. In this paper, approximate analytical solutions to KP model are represented by using the differential transform and Adomian decomposition. The complicated nonlinearity of the KP system causes the application of these two methods to require more involved calculations. The approximate analytical solutions to the model are compared with the results obtained by numerical fourth order Runge-Kutta method.
Reference Key
ahrabi2018approximate Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Alireza Momenzadeh; Sima Sarv Ahrabi
Journal arXiv
Year 2018
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.